Page 2 - Asserted Claims News Today

- Jury Upholds Validity of Asserted Claims of the Patent, Finds Willful Infringement and Issues Past Damages Award of $41.82 Million - - Seagen to Req

Our review found just four cases where a jury addressed some aspect of Section 101, all from the Eastern District of Texas….

To embed, copy and paste the code into your website or blog: On January 14, 2020, the Federal Court released a decision by Phelan J. in patent infringement actions pursuant to subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations ( PMNOC Regulations) relating to the drug abiraterone acetate (Janssen’s ZYTIGA). The Court found Canadian Patent No. 2,661,422 (the 422 patent) invalid on the basis of obviousness and dismissed the Plaintiffs’ actions against Apotex, Dr. ...

On January 14, 2021, the Federal Court issued a decision ( Janssen Inc. et al v. Apotex Inc. et al, 2021 FC 7) in the consolidated infringement action brought under s. 6(1) of the Patented Medicine (Notice of Compliance) (PM(NOC)) Regulations by Janssen against Apotex, Dr. Reddys Laboratory, and Pharmascience. In this decision, the Court invalidated the asserted claims of Janssens Canadian Patent 2,661,422 (the 422 Patent), which claimed the combined use of the two active ingredients found in J...